AK Medical Holdings Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,482	1,346	1,094	1,052	761.44
Revenue Growth (YoY)	10.11%	23.09%	3.98%	38.16%	-26.46%
Cost of Revenue	585.04	538.18	419.38	415.61	262.25
Gross Profit	897.4	808.19	674.49	636.44	499.19
Selling, General & Admin	417.58	384.86	352.25	298.42	292.66
Research & Development	136.02	139.21	137.13	110.87	113.07
Other Operating Expenses	-30.09	-16.65	-26.37	-11.19	-5.98
Operating Expenses	523.52	507.41	463	398.09	399.75
Operating Income	373.88	300.78	211.48	238.34	99.44
Interest Expense	-2.94	-0.92	-1.29	-2.17	-1.61
Interest & Investment Income	29.39	23.37	22.77	17.75	8.99
Currency Exchange Gain (Loss)	-5.35	-3.41	-1.85	4.73	1.74
EBT Excluding Unusual Items	394.98	319.82	231.12	258.65	108.56
Impairment of Goodwill	-	-	-	-18.36	-
Pretax Income	394.98	319.82	231.12	240.29	108.56
Income Tax Expense	55.89	45.9	49.01	35.52	15.94
Net Income	339.09	273.93	182.1	204.77	92.62
Net Income to Common	339.09	273.93	182.1	204.77	92.62
Net Income Growth	23.79%	50.42%	-11.07%	121.09%	-70.50%
Shares Outstanding (Basic)	1,117	1,116	1,113	1,109	1,113
Shares Outstanding (Diluted)	1,120	1,119	1,119	1,117	1,121
Shares Change (YoY)	0.10%	-0.05%	0.15%	-0.28%	1.21%
EPS (Basic)	0.30	0.25	0.16	0.18	0.08
EPS (Diluted)	0.30	0.24	0.16	0.18	0.08
EPS Growth	24.18%	52.50%	-11.11%	125.00%	-71.43%
Free Cash Flow	290.31	298.25	-149.86	127.72	117.86
Free Cash Flow Per Share	0.26	0.27	-0.13	0.11	0.10
Dividend Per Share	0.118	0.072	0.041	0.053	0.020
Dividend Growth	63.89%	76.27%	-23.04%	160.59%	-39.53%
Gross Margin	60.54%	60.03%	61.66%	60.49%	65.56%
Operating Margin	25.22%	22.34%	19.33%	22.66%	13.06%
Profit Margin	22.87%	20.34%	16.65%	19.46%	12.16%
Free Cash Flow Margin	19.58%	22.15%	-13.70%	12.14%	15.48%
EBITDA	465.33	377.69	282.36	300.3	156.85
EBITDA Margin	31.39%	28.05%	25.81%	28.54%	20.60%
D&A For EBITDA	91.45	76.91	70.88	61.95	57.42
EBIT	373.88	300.78	211.48	238.34	99.44
EBIT Margin	25.22%	22.34%	19.33%	22.66%	13.06%
Effective Tax Rate	14.15%	14.35%	21.21%	14.78%	14.68%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.